Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Rachael L Bosma

2 papers in the library · 5 citations · publishing 2024-2025

Papers

Pretreatment Brain White Matter Integrity Associated With Neuropathic Pain Relief and Changes in Temporal Summation of Pain Following Ketamine.

The journal of pain September 1, 2024 Emily P Mills, Rachael L Bosma, Anton Rogachov et al. 5 citations

In people with neuropathic pain, white matter structure in the default mode network and a pathway connecting the medial prefrontal cortex to the periaqueductal gray is linked to how much ketamine reduces central sensitization, a key pain mechanism. Among 35 patients treated with ketamine, pretreatment fiber density in the anterior limb of the internal capsule correlated with pain relief (r = 0.48), and fiber density in the default mode network (r = 0.52) and the medial prefrontal cortex-periaqueductal gray pathway (r = 0.42) correlated with reduced temporal summation of pain, a marker of central sensitization. However, white matter structure did not distinguish responders from nonresponders.

A Multi-Site, Randomized, Parallel-Group, Controlled Trial of Virtually-Delivered Sahaj Samadhi Meditation for the Management of Moderate Depressive Symptoms in Chronic Pain.

Journal of Pain Research January 1, 2025 Darren K Cheng, Robert Simpson, Rahim Moineddin et al.

A virtual Sahaj Samadhi Meditation program did not significantly outperform an active control (Health Enhancement Program) in reducing depressive symptoms among people with chronic pain and moderate depression. Within the meditation group, depressive symptoms decreased by an average of 3.97 points on the PHQ-9 at 12 weeks and 4.96 points at 24 weeks, both exceeding the minimal clinically important difference, while the control group showed no significant change. The trial enrolled 108 participants, with 89 randomized. The findings suggest potential benefits of the meditation program, but larger trials under non-pandemic conditions are needed to confirm effectiveness.